Where I’d invest $2,000 in ASX 200 shares

If I had $2,000 to invest in ASX 200 shares, I would want to be selective.

The ASX has no shortage of large companies, but I would be looking for businesses with durable market positions, sensible growth options, and the ability to keep rewarding shareholders over time.

With that in mind, here are three ASX 200 shares I would consider buying.

Cochlear Ltd (ASX: COH)

Cochlear is one ASX 200 share I would happily add to a long-term portfolio.

The company is a global leader in implantable hearing solutions. That gives it exposure to a need that is unlikely to disappear. Hearing loss can affect communication, confidence, work, education, and social connection, so the value of a successful hearing solution can be very high for patients.

What I like about Cochlear is that it is not just selling a device. It operates in a specialist healthcare market where clinical relationships, surgeon training, product reliability, software, upgrades, and long-term patient support all count. That can create a powerful ecosystem.

The company also has a long runway as populations age and awareness of hearing loss improves. Access and affordability can still vary significantly across countries, which means Cochlear’s opportunity is not limited to one mature market.

The share price can be sensitive to currency movements, hospital activity, competition, and valuation expectations. But if I were investing with a multi-year view, I think Cochlear’s combination of healthcare need, global reach, and specialist expertise would make it a strong candidate.

Wesfarmers Ltd (ASX: WES)

Wesfarmers is another ASX 200 share I would consider buying.

I think the appeal comes from the way the company thinks about capital. Wesfarmers has a long history of owning businesses, improving them, reinvesting where it sees attractive returns, and making changes when the opportunity set shifts. That gives it a different feel to a simple retailer.

Its major retail operations give the group exposure to everyday consumer spending, home improvement, value-focused shopping, office products, health, and industrial activity. But I think the more important point is that Wesfarmers has shown discipline across many cycles.

The company tends to focus on productivity, customer value, supply chains, data, and operational improvement. Those things may not sound exciting, but they can make a big difference over long periods.

A premium valuation is often the main challenge with Wesfarmers. It is rarely ignored by the market. Even so, I think a high-quality business that keeps finding ways to improve can still be worth owning for the long term.

National Australia Bank Ltd (ASX: NAB)

National Australia Bank is a bank share I would include in this group.

NAB gives investors exposure to the Australian economy through home lending, deposits, business banking, and everyday financial services. What makes it particularly interesting to me is its strength in business banking.

Small and medium-sized businesses need banking relationships, credit, payments, accounts, and advice as they grow. NAB has a strong position in that part of the market, which gives it a slightly different profile to a purely mortgage-focused bank.

Banks can be cyclical. Bad debts, funding costs, competition, regulation, and housing market conditions all need to be watched. But I think NAB offers a reasonable mix of income, scale, and economic exposure.

For a $2,000 investment, I would not be buying NAB because I expect spectacular growth. I would be buying it because a strong bank can provide a useful backbone to a portfolio, especially if dividends are reinvested over time.

Foolish takeaway

If I had $2,000 to invest in ASX 200 shares, I would focus on quality rather than trying to find the most exciting short-term idea.

I would want businesses that can stay useful, reinvest sensibly, and keep creating value through different market conditions. These three shares are not risk-free, and they will not all perform well at the same time. But I think they offer a sensible mix of healthcare, consumer, and financial exposure.

For me, that would be a practical way to put $2,000 to work with a long-term mindset.

The post Where I’d invest $2,000 in ASX 200 shares appeared first on The Motley Fool Australia.

More reading

• How to invest in ASX shares when you can’t find stocks to buy
• How I’d choose the best ASX shares I could hold for 10 years
• Which Aussie blue-chip stock is the best performer so far in 2026?
• Wesfarmers shares have surged 20% in a month. Buy now?
• Warning! 5 ASX stocks to fall 20% or more: Experts

Motley Fool contributor Grace Alvino has positions in Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and Wesfarmers. The Motley Fool Australia has recommended Cochlear and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.